209 related articles for article (PubMed ID: 2785966)
21. Anti-cholera toxin IgA-, IgG- and IgM-secreting cells in various rat lymphoid tissues after repeated intestinal or parenteral immunizations.
Solbreux PM; Dive C; Vaerman JP
Immunol Invest; 1990; 19(5-6):435-51. PubMed ID: 2074113
[TBL] [Abstract][Full Text] [Related]
22. Correlation between intestinal synthesis of specific immunoglobulin A and protection against experimental cholera in mice.
Svennerholm A; Lange S; Holmgren J
Infect Immun; 1978 Jul; 21(1):1-6. PubMed ID: 711308
[TBL] [Abstract][Full Text] [Related]
23. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
Kato H; Fujihashi K; Kato R; Yuki Y; McGhee JR
J Immunol; 2001 Mar; 166(5):3114-21. PubMed ID: 11207263
[TBL] [Abstract][Full Text] [Related]
24. Differences in cross-protection in rats immunized with the B subunits of cholera toxin and Escherichia coli heat-labile toxin.
Klipstein FA; Engert RF; Clements JD; Houghten RA
Infect Immun; 1984 Mar; 43(3):811-6. PubMed ID: 6365784
[TBL] [Abstract][Full Text] [Related]
25. Antitoxic cholera immunity in mice: influence of antigen deposition on antitoxin-containing cells and protective immunity in different parts of the intestine.
Lange S; Nygren H; Svennerholm AM; Holmgren J
Infect Immun; 1980 Apr; 28(1):17-23. PubMed ID: 7189747
[TBL] [Abstract][Full Text] [Related]
26. Stimulation of antigen-specific T- and B-cell memory in local as well as systemic lymphoid tissues following oral immunization with cholera toxin adjuvant.
Vajdy M; Lycke N
Immunology; 1993 Oct; 80(2):197-203. PubMed ID: 7505255
[TBL] [Abstract][Full Text] [Related]
27. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.
Blanchard TG; Lycke N; Czinn SJ; Nedrud JG
Immunology; 1998 May; 94(1):22-7. PubMed ID: 9708182
[TBL] [Abstract][Full Text] [Related]
28. The origin and antigen-dependent distribution of IgA-containing cells in the intestine.
Husband AJ; Gowans JL
J Exp Med; 1978 Nov; 148(5):1146-60. PubMed ID: 722238
[TBL] [Abstract][Full Text] [Related]
29. Immune response of the female rat genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit.
Menge AC; Michalek SM; Russell MW; Mestecky J
Infect Immun; 1993 May; 61(5):2162-71. PubMed ID: 8478106
[TBL] [Abstract][Full Text] [Related]
30. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
[TBL] [Abstract][Full Text] [Related]
31. Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization.
Holmgren J; Svennerholm AM; Ouchterlony O; Anderson A; Walletström G; Westerberg-Berndtsson U
Infect Immun; 1975 Dec; 12(6):1331-40. PubMed ID: 54337
[TBL] [Abstract][Full Text] [Related]
32. HMGB1 released from intestinal epithelia damaged by cholera toxin adjuvant contributes to activation of mucosal dendritic cells and induction of intestinal cytotoxic T lymphocytes and IgA.
Wakabayashi A; Shimizu M; Shinya E; Takahashi H
Cell Death Dis; 2018 May; 9(6):631. PubMed ID: 29795370
[TBL] [Abstract][Full Text] [Related]
33. Mucosal and systemic immune responses to measles virus haemagglutinin in mice immunized with a recombinant vaccinia virus.
Etchart N; Wild F; Kaiserlian D
J Gen Virol; 1996 Oct; 77 ( Pt 10)():2471-8. PubMed ID: 8887480
[TBL] [Abstract][Full Text] [Related]
34. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens.
Lycke N; Holmgren J
Immunology; 1986 Oct; 59(2):301-8. PubMed ID: 3021614
[TBL] [Abstract][Full Text] [Related]
35. Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization.
Vajdy M; Lycke NY
Immunology; 1992 Mar; 75(3):488-92. PubMed ID: 1572696
[TBL] [Abstract][Full Text] [Related]
36. Local and systemic antibody responses to dextran-cholera toxin B subunit conjugates.
Bergquist C; Lagergård T; Lindblad M; Holmgren J
Infect Immun; 1995 May; 63(5):2021-5. PubMed ID: 7537252
[TBL] [Abstract][Full Text] [Related]
37. Differential effect of aging on B-cell immune responses to cholera toxin in the inductive and effector sites of the mucosal immune system.
Haq JA; Szewczuk MR
Infect Immun; 1991 Sep; 59(9):3094-100. PubMed ID: 1879933
[TBL] [Abstract][Full Text] [Related]
38. CC chemokine ligands 25 and 28 play essential roles in intestinal extravasation of IgA antibody-secreting cells.
Hieshima K; Kawasaki Y; Hanamoto H; Nakayama T; Nagakubo D; Kanamaru A; Yoshie O
J Immunol; 2004 Sep; 173(6):3668-75. PubMed ID: 15356112
[TBL] [Abstract][Full Text] [Related]
39. Induction of an enteric Ig-response against ovalbumin and stimulation of the response by cholera toxin and its B-subunit in mice.
Bianchi AT; Zwart RJ; Van der Heijden PJ
Reg Immunol; 1990-1991; 3(3):131-8. PubMed ID: 2098068
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo.
Apter FM; Michetti P; Winner LS; Mack JA; Mekalanos JJ; Neutra MR
Infect Immun; 1993 Dec; 61(12):5279-85. PubMed ID: 8225601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
